| Line Item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
|---|---|---|---|---|---|
| Consolidated Statements of Net Loss and Comprehensive Loss | |||||
| Revenue | |||||
| Cost of sales | |||||
| Gross profit (loss) | |||||
| Operating expenses | |||||
| General and administrative | |||||
| Selling and marketing | |||||
| Research and development, net | |||||
| Share-based compensation | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expenses) | |||||
| Share issuance costs | |||||
| Net finance costs | |||||
| Foreign exchange gain (loss) | |||||
| Impairment of right-of-use assets | |||||
| Gain/loss on disposals | |||||
| Change in fair value of warrant liabilities | |||||
| Total other income (expenses), net | |||||
| Loss before income taxes | |||||
| Net loss |